[{"address1": "7800 Susquehanna St.", "address2": "Suite 505", "city": "Pittsburgh", "state": "PA", "zip": "15208", "country": "United States", "phone": "412 894 1853", "website": "https://lipella.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan  Kaufman M.B.A., Ph.D.", "age": 57, "title": "Co-Founder, Chairman, CEO, President, Secretary & Treasurer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 233300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael B. Chancellor M.D.", "age": 65, "title": "Co-Founder, Chief Medical Officer & Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 225000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas  Johnston CPA", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 165000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele  Gruber", "title": "Director of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janet  Okonski", "title": "Director of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katie  Johnston", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9, "open": 0.91, "dayLow": 0.9, "dayHigh": 0.965, "regularMarketPreviousClose": 0.9, "regularMarketOpen": 0.91, "regularMarketDayLow": 0.9, "regularMarketDayHigh": 0.965, "payoutRatio": 0.0, "beta": 0.458, "forwardPE": -0.3015625, "volume": 4600, "regularMarketVolume": 4600, "averageVolume": 89282, "averageVolume10days": 108870, "averageDailyVolume10Day": 108870, "bid": 0.9, "ask": 1.0, "bidSize": 2170, "askSize": 1093, "marketCap": 4311041, "fiftyTwoWeekLow": 0.621, "fiftyTwoWeekHigh": 12.0, "priceToSalesTrailing12Months": 8.292584, "fiftyDayAverage": 2.4526, "twoHundredDayAverage": 2.846335, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -180301, "profitMargins": 0.0, "floatShares": 4175897, "sharesOutstanding": 4467400, "sharesShort": 100093, "sharesShortPriorMonth": 133447, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0224, "heldPercentInsiders": 0.06525, "heldPercentInstitutions": 0.014140001, "shortRatio": 3.32, "shortPercentOfFloat": 0.0235, "impliedSharesOutstanding": 4467400, "bookValue": 1.6, "priceToBook": 0.603125, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -5130978, "trailingEps": -4.12, "forwardEps": -3.2, "lastSplitFactor": "1:8", "lastSplitDate": 1731024000, "enterpriseToRevenue": -0.347, "enterpriseToEbitda": 0.035, "52WeekChange": -0.75, "SandP52WeekChange": 0.12748289, "quoteType": "EQUITY", "currentPrice": 0.965, "recommendationKey": "none", "totalCash": 4225012, "totalCashPerShare": 0.946, "ebitda": -5187830, "totalDebt": 23997, "quickRatio": 5.549, "currentRatio": 6.209, "totalRevenue": 519867, "debtToEquity": 0.588, "revenuePerShare": 0.39, "returnOnAssets": -0.81174004, "returnOnEquity": -1.54536, "grossProfits": -3244195, "freeCashflow": -2100415, "operatingCashflow": -3988435, "revenueGrowth": -0.113, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -10.262159, "financialCurrency": "USD", "symbol": "LIPO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Lipella Pharmaceuticals Inc.", "longName": "Lipella Pharmaceuticals Inc.", "exchange": "NCM", "messageBoardId": "finmb_35907207", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 7.2222223, "regularMarketPrice": 0.965, "corporateActions": [], "regularMarketTime": 1751042363, "marketState": "CLOSED", "hasPrePostMarketData": true, "regularMarketChange": 0.065, "regularMarketDayRange": "0.9 - 0.965", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 89282, "fiftyTwoWeekLowChange": 0.34399998, "fiftyTwoWeekLowChangePercent": 0.55394524, "fiftyTwoWeekRange": "0.621 - 12.0", "fiftyTwoWeekHighChange": -11.035, "fiftyTwoWeekHighChangePercent": -0.9195833, "fiftyTwoWeekChangePercent": -75.0, "epsTrailingTwelveMonths": -4.12, "epsForward": -3.2, "fiftyDayAverageChange": -1.4876001, "fiftyDayAverageChangePercent": -0.60654, "twoHundredDayAverageChange": -1.881335, "twoHundredDayAverageChangePercent": -0.6609675, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-12-20", "cryptoTradeable": false, "firstTradeDateMilliseconds": 1671460200000, "displayName": "Lipella Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-06-28"}]